Recommendations for Complying With the Pediatric Rule (21 CFR 314.55(a) and...
...Pre-investigational new drug application meetings should include plans for studying the.....Under the Pediatric Rule you may be required to produce a pediatric formulation if one is.....It is usually prudent to begin the development of a pediatric formulation before..
http://www.fda.gov/cder/guidance/3578dft.htm (score=100)

FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...In addition, careful control of the impurities and degradation products in the drug substance and drug formulation.....In addition, careful control of the impurities and degradation products in the drug substance and other drug formulation.....Therefore, when balanced with the other factors, the drug formulation of sterile products does..
http://www.fda.gov/cder/fdama/difconc.htm (score=294)

MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....an internal reservoir containing sufficient formulation for multiple doses that are.....formulation, moisture level, consistency of filling operation, particle size distribution..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=127)

FDA Drug Approvals List
...For a complete listing of new drug approvals for a particular month, see the Approved Drug.....A product that duplicates another firm's already marketed drug product: same active ingredient, formulation, or combination. 6.....For daily new drug and generic approval information, please see CDER New and Generic Drug..
http://www.fda.gov/cder/da/da.htm (score=119)

Document
...as safe and effective and not misbranded active ingredients in OTC drug products document.....Even minor variations in formulation, effectiveness. formula is stated as: such as the.....The submitted information does antifungal drug products (December 12, chromatographic..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03-14140.pdf (score=101)

...Department of Health and Human Services Food and Drug Administration Center for Drug.....Under the Pediatric Rule you may be required to produce a pediatric formulation if one is.....Department of Health and Human Services Food and Drug Administration Center for Drug..
http://www.fda.gov/cder/guidance/3578dft.doc (score=99)

FR Doc 03-14140
...The OTC drug review was designed to implement both the misbranding and the new drug.....Subjects applied the antiperspirant test formulation to one axilla and used either a.....Any drug product labeled, represented, or promoted for use as an OTC antiperspirant drug..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03-14140.htm (score=98)

WAIS Document Retrieval
...Such a product may, however, be subject to regulation as a drug and as a new drug, under.....The potential for titanium dioxide particles to agglomerate in formulation, which could.....Any drug product labeled, represented, or promoted for use as an OTC sunscreen drug that..
http://www.fda.gov/cder/fdama/fedreg/sunscreen.txt (score=98)

þÿ
...formulation components or leaching from the container closure system, chemical impurities.....adequate acceptance criteria to ensure that batches of drug products meet each appropriate.....1 This guidance has been prepared by the Inhalation Drug Products LDPE Working Group of..
http://www.fda.gov/cder/guidance/4168dft.pdf (score=97)

March/April 1997 FDA Veterinarian Newsletter
...The highest assurance for safe and effective use of a drug comes when the available drug.....Are there any additional conditions that must be met to use either a human drug or an animal drug that has.....Equine practitioners often must treat animals where no approved formulation exists, or..
http://www.fda.gov/cvm/index/fdavet/1997/march.htm (score=94)

April 2000 Safety-Related Drug Labeling Changes
...To reduce the chance of a drug-drug interaction, cyclosporine should be taken at least 2 hours.....Therefore, if Agenerase is used in pregnant women, the Agenerase Capsules formulation.....Subsection reordered with separate paragraphs for drugs/drug categories, with the text..
http://www.fda.gov/medwatch/safety/2000/apr00.htm (score=94)

Paxil CR
...of the immediate-release formulation of 20 mg to 40 mg daily for the elderly and 20 mg to.....Based on studies using immediate-release formulations, steady-state drug exposure based on.....Long-term maintenance of efficacy with the immediate-release formulation of paroxetine was..
http://www.fda.gov/medwatch/SAFETY/2004/PaxilCR_PI.pdf (score=94)

Variations in Drug Products that May be included in a Single A
...In this case,the studies are not related to a difference in formulation but have been.....Prior to October 1, 1990, applicants were to submit separate ANDAs for each drug dosage.....submitting and maintaining separate applications for certain variations of the same drug..
http://www.fda.gov/cder/guidance/2090fnl.pdf (score=93)

...So, the bottom line is that 17 this drug did not work with the best possible 18 formulation in this population and, therefore, 19.....1 DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH PEDIATRIC.....There is no marketable 16 age-appropriate formulation for children 6 months 17 to 6 years..
http://www.fda.gov/ohrms/dockets/ac/04/transcripts/2004-4050T1.DOC (score=92)

Document
...to convene a panel of pediatric experts, existing drug advisory committees, FDA agrees.....The AAP stated that premature infants, formulation had failed. compound is cleared from.....early as possible in drug development. protocol finalization, enrollment, formulation..
http://www.fda.gov/ohrms/dockets/98fr/120298c.pdf (score=92)

þÿ
...elderly and nonelderly patients, at doses of the immediate-release formulation of 20 to 40.....addition to controlling the rate of drug release in vivo,an enteric coat delays the start.....Long-term maintenance of efficacy with the immediate-release formulation of paroxetine was..
http://www.fda.gov/cder/foi/label/2002/20982lbl.pdf (score=91)

/a/content.30891
...all the clinical data on the to-be-marketed formulation, 6.. even if it is more than one.....rate and extent of drug absorption, its pharmacokinetics, 16.. pharmacodynamics, and the.....slight changes in the formulation on product variability, 19.. because they may have made..
http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3657t2.pdf (score=91)

Frequently Asked Questions on Pediatric Exclusivity, etc.
...Only drug products subject to section 505 of the Food, Drug, and Cosmetic Act are eligible.....For example, if a firm markets an oral formulation, a topical cream, and an ophthalmic.....Inclusion of a drug on the list does not necessarily mean that the drug is entitled to..
http://www.fda.gov/cder/pediatric/faqs.htm (score=91)

/a/content.11865
...For the patent referenced above, provide the following information on the drug substance, drug product and.....Drug Product (Composition/Formulation) 3.1 Does the patent claim the drug product, as defined in 21 CFR 314.3, in.....53(d) to change the formulation, add a new.. method of using the approved drug product to..
http://www.fda.gov/opacom/morechoices/fdaforms/FDA-3542a.pdf (score=91)

þÿ

http://www.fda.gov/cder/foi/label/2002/21360lbl.pdf (score=91)

Las Vegas Injury Lawyer